The Lupus Anticoagulant Paradox
Authors:
- 12 September 2017
- journal article
- review article
- Published by Georg Thieme Verlag KG in Seminars in Thrombosis and Hemostasis
- Vol. 44 (05) , 445-452
Abstract
Lupus anticoagulant (LA) represents the most enigmatic antibody population in patients with antiphospholipid syndrome and represents a paradox that is still unsolved. This class of antiphospholipid antibody causes a phospholipid-dependent prolongation of the clotting time but is associated with an increased risk of thrombosis and pregnancy morbidity. In this review, we will provide an overview of the different antibodies that have been associated with LA activity, their importance based on clinical studies, and address the question why this prolongation of the clotting time is associated with thrombosis rather than a bleeding tendency.Keywords
This publication has 41 references indexed in Scilit:
- Guidelines on the investigation and management of antiphospholipid syndromeBritish Journal of Haematology, 2012
- Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up studyAnnals of the Rheumatic Diseases, 2011
- Risk assessment for recurrent venous thrombosisThe Lancet, 2010
- Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)Thrombosis Research, 2010
- Clinical course of high‐risk patients diagnosed with antiphospholipid syndromeJournal of Thrombosis and Haemostasis, 2010
- Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein CBlood Coagulation & Fibrinolysis, 2008
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study)Journal of Thrombosis and Haemostasis, 2005
- A two‐step coagulation test to identify antiβ2‐glycoprotein I lupus anticoagulantsJournal of Thrombosis and Haemostasis, 2004
- The Taipan snake venom time: a new test for lupus anticoagulant.Journal of Clinical Pathology, 1994